Breast cancer cells are hormone receptor-positive if they express either (or both) of the estrogen and/or progesterone receptors and are considered HER-2-positive if the breast cancer cells overexpress the protein, HER-2 (human epidermal growth factor receptor 2). This evidence concerns the gene ERBB2 and breast carcinoma.